NCAM1 and melanoma: It was reported earlier that in patients with regressing melanoma the population of peripheral blood cells expressing CD56 increased following PD-1 blockade treatment.[8] In our study, no increase in the total number of CD56+ cells was observed after PD-1 blockade treatment (Table 1).